Jan Frykhammar
Analyst · Goldman Sachs. Please go ahead. Your line is open
Okay. Alex, Jan here. No, I think the reason that we want to – the reason that we really want to disclose this baseline number is, of course, that we feel we have not been, I think, clear enough on what is the underlying baseline number on all the contracts we have. So I think the way to look at this is, of course, that this is a number that reflects the contracts we have, but also with the given volumes and mix we have in the end of the year. And of course, in reality then this might be – our view is that we should look at this, of course as some kind of baseline number and then on top of that, there might be of course new contracts coming in, new signed contracts, which we all know is an ambition we have to make sure that all handset manufacturers are licensed, to start with. I think the other aspect is, of course, that that there is always deals going on. We can be selling patents. We can be settle deals. There could be deals that has an element of forward-looking running royalties, but also settlements going backwards and so forth. And if we look back a few years, that has been the case, but I think, view this more as a baseline number. And then obviously from there, we can then also discuss with you in a better way on a quarterly basis. Now, we deviate from the baseline because of X, Y, Z, something like that. So that’s how I want you or how we want you to think about this number. So it’s – nothing has really happened in the market around price reductions or structural changes, it’s just a way for us to try to be better in communicating around this portfolio.